Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY.
Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine, Mount Sinai Medical Center and Health System, New York, NY.
J Allergy Clin Immunol Pract. 2024 Sep;12(9):2260-2267. doi: 10.1016/j.jaip.2024.05.035. Epub 2024 May 29.
Contact dermatitis (CD) is a common and burdensome condition divided into irritant contact dermatitis and allergic contact dermatitis. Treatment relies on accurate diagnosis and identification of the trigger, because definitive treatment is irritant or allergen avoidance. However, avoidance is not always possible, such as when the patient is reacting to a necessary medical device, when the trigger is integral to the patient's occupation, and when avoidance is practically untenable. In these cases, treatment is particularly challenging, especially because the literature on treatments in this clinical scenario is limited. In addition, CD has a complex pathophysiology that varies according to the trigger type, leading to variable treatment efficacy. This article reviews the current literature on treatments for CD with a focus on treatments when trigger avoidance is not feasible.
接触性皮炎(CD)是一种常见且麻烦的疾病,分为刺激性接触性皮炎和过敏性接触性皮炎。治疗依赖于准确的诊断和触发因素的识别,因为明确的治疗方法是避免刺激物或过敏原。然而,避免接触并不总是可行的,例如当患者对必要的医疗器械产生反应时,当触发因素是患者职业的一部分时,或者当避免接触实际上不可行时。在这些情况下,治疗特别具有挑战性,特别是因为文献中关于这种临床情况下的治疗方法有限。此外,CD 的病理生理学很复杂,根据触发因素的类型而有所不同,导致治疗效果不同。本文综述了 CD 治疗的现有文献,重点介绍了在无法避免触发因素时的治疗方法。